HDP-101 is an RNA polymerase II ADC targeting anti–B cell maturation antigen (anti-BCMA) with an amanitin derivative and has shown ability to block tumor growth in both proliferating and resting multiple myeloma BCMA-positive cells (102). Here, TNFRSF17 is linked to plasma cell myeloma.